David Gallinson
Impact in
Papers in
- Co-authors
- Christine Lihou (8 shared papers)Efrat Dotan (8 shared papers)Adrian Murphy (8 shared papers)Daniel V.T. Catenacci (8 shared papers)Antoine Hollebecque (8 shared papers)Hui‐Ling Zhen (7 shared papers)Davide Melisi (8 shared papers)Gina M. Vaccaro (8 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (3 papers)Blood (2 papers)ESMO Open (1 paper)Clinical Colorectal Cancer (1 paper)
- Partner nations
- United StatesSouth KoreaItaly
In The Last Decade
David Gallinson
17 papers receiving 1.1k citations
David Gallinson's Hit Papers
Peers
Comparison fields: 5 of 49
- Oncology 624
- Surgery 813
- Pulmonary and Respiratory Medicine 380
- Cancer Research 172
- Pathology and Forensic Medicine 177
Countries citing papers authored by David Gallinson
This map shows the geographic impact of David Gallinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gallinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gallinson more than expected).
Fields of papers citing papers by David Gallinson
This network shows the impact of papers produced by David Gallinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gallinson. The network helps show where David Gallinson may publish in the future.
Co-authors
The 25 scholars most cited alongside David Gallinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study Hit paper breakdown → | 2020 | 975 |
| 2 | 2019 | 42 | |
| 3 | 2013 | 30 | |
| 4 | 2021 | 19 | |
| 5 | 2022 | 17 | |
| 6 | 2024 | 16 | |
| 7 | 2024 | 5 | |
| 8 | 2021 | 5 | |
| 9 | 2022 | 4 | |
| 10 | 2025 | 3 | |
| 11 | 2024 | 3 | |
| 12 | 2019 | 2 | |
| 13 | 2022 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2012 | 1 | |
| 17 | Clinical practice issues in oncology impacted by healthcare reform. | 2012 | 1 |
About David Gallinson
David Gallinson is a scholar working on Oncology, Surgery, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Fibroblast Growth Factor Research (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Peptidase Inhibition and Analysis (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Oncology (624 citations), Surgery (813 citations), Pulmonary and Respiratory Medicine (380 citations), Cancer Research (172 citations) and Pathology and Forensic Medicine (177 citations). David Gallinson has collaborated with scholars based in United States, South Korea and Italy. Frequent co-authors include Christine Lihou, Efrat Dotan, Adrian Murphy, Daniel V.T. Catenacci, Antoine Hollebecque, Hui‐Ling Zhen, Davide Melisi, Gina M. Vaccaro, Ghassan K. Abou‐Alfa and Arndt Vogel. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, ESMO Open and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.